Table 3.
Variables1 | OR | 95% CI | p |
---|---|---|---|
Pain | |||
Gender (female) | 1.402 | 0.929 − 2.115 | 0.107 |
Body weight | 0.987 | 0.977 − 0.996 | 0.007 |
Disease stage | 0.944 | 0.735 − 1.213 | 0.653 |
Weight loss | 1.023 | 1.007 − 1.040 | 0.005 |
Metastasis | 1.727 | 1.102 − 2.708 | 0.017 |
TST | 0.986 | 0.977 − 0.994 | 0.001 |
Tiredness | |||
Body weight | 0.982 | 0.971 − 0.993 | 0.002 |
Disease stage | 1.130 | 0.861 − 1.484 | 0.378 |
Weight loss | 1.031 | 1.002 − 1.060 | 0.037 |
Metastasis | 1.537 | 0.914 − 2.587 | 0.105 |
Drowsiness | |||
Age | 1.010 | 0.996 − 1.024 | 0.152 |
Body weight | 0.997 | 0.987 − 1.006 | 0.524 |
Disease stage | 1.032 | 0.803 − 1.326 | 0.807 |
Comorbidity | 1.264 | 0.979 − 1.632 | 0.072 |
Weight loss | 1.044 | 1.021 − 1.067 | <0.0001 |
Metastasis | 1.640 | 1.048 − 2.567 | 0.031 |
TST | 0.990 | 0.987 − 0.998 | 0.020 |
Nausea | |||
Age | 0.985 | 0.972 − 0.997 | 0.017 |
Body weight | 0.991 | 0.982 − 1.000 | 0.057 |
Disease stage | 1.020 | 0.790 − 1.317 | 0.881 |
Weight loss | 1.030 | 1.011 − 1.050 | 0.002 |
Metastasis | 1.276 | 0.814 − 2.001 | 0.289 |
TST | 0.986 | 0.977 − 0.995 | 0.004 |
Lack of appetite | |||
Age | 1.008 | 0.993 − 1.022 | 0.314 |
Body weight | 0.970 | 0.960 − 0.980 | <0.001 |
Disease stage | 1.172 | 0.903 − 1.520 | 0.234 |
Comorbidity | 1.463 | 1.114 − 1.921 | 0.006 |
Weight loss | 1.046 | 1.022 − 1.072 | <0.001 |
Metastasis | 1.477 | 0.924 − 2.361 | 0.103 |
TST | 0.987 | 0.972 − 0.991 | <0.001 |
Shortness of breath | |||
Age | 1.005 | 0.991 − 1.019 | 0.502 |
Body weight | 0.984 | 0.975 − 0.993 | 0.001 |
Comorbidity | 1.903 | 1.462 − 2.477 | <0.001 |
Depression | |||
Gender (female) | 1.777 | 1.210 − 2.610 | 0.003 |
Body weight | 0.988 | 0.979 − 0.997 | 0.010 |
Disease stage | 1.065 | 0.826 − 1.374 | 0.626 |
Comorbidity | 1.421 | 1.116 − 1.809 | 0.004 |
Weight loss | 1.042 | 1.021 − 1.063 | <0.0001 |
Metastasis | 1.353 | 0.863 − 2.119 | 0.187 |
TST | 0.988 | 0.979 − 0.997 | 0.009 |
Anxiety | |||
Age | 1.010 | 0.996 − 1.023 | 0.167 |
Gender (female) | 1.791 | 1.195 − 2.684 | 0.005 |
Body weight | 0.991 | 0.982 − 1.001 | 0.071 |
Disease stage | 1.088 | 0.846 − 1.401 | 0.511 |
Comorbidity | 1.238 | 0.961 − 1.594 | 0.098 |
Weight loss | 1.040 | 1.018 − 1.062 | <0.0001 |
Metastasis | 1.328 | 0.848 − 2.079 | 0.215 |
TST | 0.992 | 0.983 − 1.001 | 0.077 |
Poor well-being | |||
Age | 1.028 | 1.013 − 1044 | <0.0001 |
Body weight | 0.981 | 0.971 − 0.991 | <0.0001 |
Disease stage | 0.998 | 0.770 − 1.294 | 0.990 |
Comorbidity | 1.198 | 0.903 − 1.590 | 0.211 |
Weight loss | 1.049 | 1.022 − 1.077 | <0.0001 |
Metastasis | 2.168 | 1.349 − 3.484 | 0.001 |
TST | 0.991 | 0.982 − 1.000 | 0.044 |
Awakening | |||
Gender (female) | 1.361 | 0.936 − 1.979 | 0.107 |
Disease stage | 1.403 | 1.080 − 1.822 | 0.011 |
Comorbidity | 1.406 | 1.107 − 1.785 | 0.005 |
Weight loss | 1.027 | 1.008 − 1.046 | 0.004 |
Metastasis | 1.291 | 0.822 − 2.027 | 0.267 |
TST, time since diagnosis.
Only variables derived from predictive factors with a significance <0.05 in the univariate analysis were included.